| 4 min read
Greater focus on non-animal testing methods in the UK, a new CRISPR treatment to lower cholesterol, and positive results for a BTK inhibitor in MS led the news this week.
| 4 min read
Ignota Labs is using artificial intelligence to revive shelved drug candidates, reduce clinical risk, and cut carbon emissions.
| 5 min read
Transcriptomics, proteomics, and functional genomics are converging to create a new era of mechanism-aware drug discovery. 
| 2 min read
Trinity College Dublin researchers report a nasal vaccine that prevented infection and spread of pertussis in preclinical models.News
| 2 min read
With so many cancer patients not responding to these immunotherapies, researchers are looking for new ways to boost their efficacy.
| 3 min read
The new therapy combines a chemically enhanced drug with tumor-targeted delivery to overcome resistance and reduce side effects.
| 3 min read
The therapy exploits the properties of a neutrophil-derived enzyme to selectively kill tumor cells while preserving healthy immune cells.
| 4 min read
FDA approvals, rejections, antibody-drug conjugate deals, and more led the news this week.
| 4 min read
Radiprodil is in development as the first therapy designed to directly address the underlying biology of GRIN-related neurodevelopmental disorder.
| 3 min read
The sensor could be used to enhance personalized medicine approaches for a variety of conditions.
Cancer Research News
Researchers highlight how intra-tumoral microbiota shape tumor growth, drug resistance, and treatment response.
Ryvu’s ONCO Prime platform uncovers novel molecular vulnerabilities and actionable targets in colorectal and other cancers.
Editor's Pick
Born to differentiate and heal, mesenchymal stem cells carry great potential for treating a wide spectrum of diseases.
In a journey fraught with heartache and persistence, medical research giants paved the way for successful bone marrow transplantation.
Multimedia
Laboratories account for a surprising share of global emissions and plastic waste, making sustainability a priority for modern research.
With diverse emerging modalities and innovative delivery strategies, RNA therapeutics are tackling complex diseases and unmet medical needs.
